| 1 | Case | 1.1% | |
| 2 | Study | 1.01% | |
| 3 | Medicina | 1.01% | |
| 4 | Report | 0.82% | |
| 5 | New | 0.73% | |
| 6 | Cancer | 0.64% | |
| 7 | Patients | 0.55% | |
| 8 | May | 0.46% | |
| 9 | Gene | 0.46% | |
| 10 | Disease | 0.46% | |
| 11 | CDC | 0.37% | |
| 12 | Risk | 0.37% | |
| 13 | Vaccine | 0.37% | |
| 14 | COVID-19 | 0.37% | |
| 15 | Syndrome | 0.27% | |
| 16 | ADHD | 0.27% | |
| 17 | Covid-19 | 0.27% | |
| 18 | Health | 0.27% | |
| 19 | Expert | 0.27% | |
| 20 | COVID | 0.27% | |
| 21 | Dysfunction | 0.27% | |
| 22 | Rare | 0.27% | |
| 23 | AI | 0.27% | |
| 24 | Lower | 0.27% | |
| 25 | FDA | 0.27% | |
| 26 | Recurrent | 0.27% | |
| 27 | Trump | 0.27% | |
| 28 | HIV | 0.27% | |
| 29 | Use | 0.27% | |
| 30 | Retrospective | 0.27% | |
| 31 | NSCLC | 0.27% | |
| 32 | Covid | 0.27% | |
| 33 | Carcinoma | 0.18% | |
| 34 | Muscle | 0.18% | |
| 35 | Colorectal | 0.18% | |
| 36 | Patient | 0.18% | |
| 37 | Kerala | 0.18% | |
| 38 | Hospital | 0.18% | |
| 39 | Therapy | 0.18% | |
| 40 | Cervical | 0.18% | |
| 41 | Quero | 0.18% | |
| 42 | Reconstruction | 0.18% | |
| 43 | Healthcare | 0.18% | |
| 44 | Need | 0.18% | |
| 45 | Bladder | 0.18% | |
| 46 | Renal | 0.18% | |
| 47 | Etienne-Emile | 0.18% | |
| 48 | Lo | 0.18% | |
| 49 | Association | 0.18% | |
| 50 | Assay | 0.18% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Gene Therapy, ASOs, and Beyond: What’s Coming for Huntington’s Disease
NeurologyLive
2025-06-01 02:02:21
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
The ASCO Post
2025-06-01 00:00:04
New immunotherapy drug doubles remission time for head and neck cancer patients
Deccan Herald
2025-05-31 19:19:54